Laboratory Historical Cash Flow
| LH Stock | USD 241.16 0.99 0.41% |
Analysis of Laboratory cash flow over time is an excellent tool to project Laboratory future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 1 B or Depreciation of 606.2 M as it is a great indicator of Laboratory ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.
Laboratory |
About Laboratory Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Laboratory balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Laboratory's non-liquid assets can be easily converted into cash.
Laboratory Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Laboratory to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Laboratory operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Laboratory financial statement analysis. It represents the amount of money remaining after all of Laboratory of operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Laboratory's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Net Income is increasing as compared to previous years. The Laboratory's current Other Non Cash Items is estimated to increase to about 715.4 M, while Free Cash Flow is projected to decrease to under 619.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 460.4M | 481.9M | 453.6M | 476.3M | Depreciation | 745.1M | 633.9M | 577.3M | 606.2M |
Laboratory cash flow statement Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (89.3M) | 983.3M | 151.9M | (1.0B) | 216.2M | 227.0M | |
| Free Cash Flow | 1.0B | 1.8B | 2.6B | 1.5B | 874.1M | 619.8M | |
| Change In Working Capital | (294.4M) | (856.9M) | (263.7M) | (603.4M) | (361.9M) | (343.8M) | |
| Begin Period Cash Flow | 426.8M | 337.5M | 1.3B | 1.5B | 320.6M | 265.8M | |
| Other Cashflows From Financing Activities | 4.7B | 242.3M | 1.9B | 709.8M | 1.5B | 1.0B | |
| Depreciation | 577.2M | 624.7M | 745.1M | 633.9M | 577.3M | 606.2M | |
| Capital Expenditures | 400.2M | 381.7M | 460.4M | 481.9M | 453.6M | 476.3M | |
| Total Cash From Operating Activities | 1.4B | 2.1B | 3.1B | 2.0B | 1.3B | 801.6M | |
| Net Income | 824.9M | 1.6B | 2.4B | 1.3B | 380.4M | 514.7M | |
| Total Cash From Financing Activities | (252.7M) | (517.4M) | (2.1B) | (1.3B) | (59.3M) | (62.3M) | |
| End Period Cash Flow | 337.5M | 1.3B | 1.5B | 430M | 536.8M | 295.5M | |
| Dividends Paid | 2.4B | 151.7M | 1B | 195.2M | (254M) | (241.3M) | |
| Sale Purchase Of Stock | (450M) | (100M) | (1.7B) | (1.1B) | (1B) | (950M) | |
| Other Non Cash Items | 200.8M | 745.8M | 170.9M | 482.4M | 681.3M | 715.4M | |
| Change To Inventory | (21.9M) | (196.6M) | 2.8M | (45.5M) | (700K) | (735K) | |
| Stock Based Compensation | 107M | 111.7M | 153.7M | 144.1M | 128.7M | 82.9M | |
| Other Cashflows From Investing Activities | 1.7M | 3.1M | (424.2M) | (1.2B) | (1.1B) | (1.0B) | |
| Change To Account Receivables | (64.1M) | (913.4M) | 222M | 15.9M | (75.3M) | (79.1M) | |
| Change To Liabilities | 25.3M | 43.1M | 34.8M | 342.4M | 393.8M | 413.4M | |
| Investments | (1.3B) | (643.2M) | (14.6M) | (1.7B) | (1.1B) | (1.1B) | |
| Net Borrowings | (409.3M) | 210.1M | (412.2M) | (375M) | (337.5M) | (320.6M) | |
| Total Cashflows From Investing Activities | (1.3B) | (643.2M) | (884.6M) | (1.7B) | (1.5B) | (1.6B) | |
| Change To Netincome | 144M | 611.1M | 56M | 646.3M | 743.2M | 780.4M | |
| Change To Operating Activities | (174.7M) | 252.5M | (344.1M) | (816.2M) | (734.6M) | (697.9M) | |
| Issuance Of Capital Stock | 64.7M | 55.9M | 51.7M | 50.6M | 54.4M | 46.2M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.